ライフサイエンスコーパス: albumin

1 effect on extravasation of 70-kDa dextran or albumin.

2 fibrinogen mass is 168% greater than that of albumin.

3 ned albumin supplements such as bovine serum albumin.

4 ate constant 0.563-fold smaller than that of albumin.

5 and high molecular mass dextran molecules or albumin.

6 two storage proteins - vicilin and a 21 kDa albumin.

7 emonstrated for a prototypical large protein-albumin.

8 was removed and replaced with 5% human serum albumin.

9 in a protein digest mixture of bovine serum albumin.

10 cles in ethanolic solutions and bovine serum albumin.

11 BCs when delivered as part of a complex with albumin.

12 e 3/4 hepatic encephalopathy, WBC count, and albumin.

13 hydrolysis and precipitation of bovine serum albumin.

14 h artificial urine spiked with 30-300 ppm of albumin.

15 to exhibit high binding affinities to serum albumin.

16 alorimetry that JMS-053 binds to human serum albumin.

17 that all drug would be bound specifically to albumin.

18 fetal bovine serum (FBS) identified as serum albumin.

19 VEGF-induced BRB permeability to Evans Blue-albumin.

20 d many mesothelin-positive cells coexpressed albumin.

21 tion increase due to their interactions with albumin.

22 fragment specific for mouse and human serum albumin.

23 capacity, transferrin saturation, and serum albumin.

24 s that is based on similarities among the 2S albumins.

25 /l p < 0.001 (95% CI - 43.64 to - 23.55) and albumin 0.29 g/dl p < 0.001 (95% CI - 0.42 to - 0.15); P

26 as enhanced 2 to 140-fold by incubation with albumin (0.38-134 mug/mL).

27 T-rich interaction domain 1A (ARID1A) (13%), albumin (11.4%), apolipoprotein B (APOB) (9.4%), and AXI

28 Serum albumin, 25(OH)D, and intact parathyroid hormone were me

29 ment, were neutropenia (48 [15%]), low serum albumin (33 [10%]), weight loss (29 [9%]), and anaemia (

30 Patients with albumin (5.5% compared with 2.6%; p = 0.001), preexistin

31 <5 L paracentesis were randomized to receive albumin (8 g/dL of ascitic fluid; n = 40) or no albumin

32 nfrared fluorescent dye-labeled bovine serum albumin (800CW-BSA, used as a model agent).

33 binding of unconjugated bilirubin (B(T) ) to albumin (A) and validate their molar concentration ratio

34 platelet (P) counts, as well as CRP (C) and albumin (A) levels were recorded.

35 Albumin accumulation in tumours could reflect a role of

36 RAR activity was repressed by acetylcholine, albumin, aldosterone, angiotensin II, high glucose, cisp

37 Human albumin, alpha(1) -antitrypsin, glypican-3, alpha-smooth

38 This model predicts albumin, alpha(1) -microglobulin (alpha(1) -m), beta(2)

39 gn a bifunctional molecule with affinity for albumin and a serum protein involved in cholesterol meta

40 of beta(2) -m and RBP4 differs from that of albumin and alpha(1) -m in their sensitivity to changes

41 ctional urinary excretion of 0.025%, whereas albumin and alpha(1) -microglobulin (alpha(1) -m) are re

42 Levels of albumin and apolipoprotein B were measured in cell cultu

43 he ability to detect miRNA-21 in human serum albumin and bovine serum albumin was almost identical to

44 eening tools, length of hospital stay, serum albumin and cholesterol concentrations, lymphocyte count

45 related albumin-binding domain (ABD) to bind albumin and evade clearance.

46 Albumin and fibrinogen cause a 52.2% and 78.2% attenuati

47 We study exchange of two blood proteins, albumin and fibrinogen, adsorbing to and competitively d

48 History of ascites, albumin and hemoglobin are major determinants of the dev

49 s closely related to the history of ascites, albumin and hemoglobin but not to tumour load or to resp

50 Similarly, among men, lower serum albumin and higher ICS were linked with higher baseline

51 bining elevated hsCRP and ESR with low serum albumin and iron], and serum interleukin (IL) 1beta were

52 high plasma levels; similarly, FcRn recycles albumin and is the portal of entry for enteric cytopathi

53 e to better maintain the native structure of albumin and its intrinsic properties.

54 Increased sodium and magnesium and decreased albumin and lactate levels were detected in animals euth

55 m tomato and mustard seeds, we identified 2S albumin and non-specific lipid transfer proteins (nsLTP)

56 Wines fined with egg albumin and plant-based proteins from potato, pea, and g

57 LMG-bovine serum albumin and rabbit anti-sheep IgG were immobilized on ni

58 Notwithstanding the majority of albumin and riboflavin was successfully removed, ca. 40-

59 time of hospital admission, serum levels of albumin and sodium, and white blood cell count, to ident

60 f the two main metal-binding serum proteins, albumin and transferrin.

61 sitivity C-reactive protein, fibrinogen, and albumin), and bone mineral metabolism (25-hydroxyvitamin

62 ats exhibited increased permeability of FITC-albumin, and a single norrin injection restored BRB prop

63 ects on inflammation, iron metabolism, serum albumin, and anti-drug antibodies.

64 reby increased affinity for lipid particles, albumin, and other plasma proteins by lipid-conjugation

65 at dialysate electrolyte composition, plasma albumin, and plasma total CO2 accurately predict the mea

66 ction with plasma biomacromolecules, such as albumin, and self-aggregation at high concentrations and

67 o methacholine, bronchoalveolar lavage fluid albumin, and serum IgE levels.

68 airment (aOR 5.14, 95%CI 2.65-9.97), and low albumin (aOR 1.06, 95%CI 1.02-1.09, increase per g decre

69 Although the 2S albumins are diverse, they have a common disulfide-linke

70 eriments provide strong evidence that the 2S albumins are the most important allergens in peanuts for

71 Using human serum albumin as a model, its sequence was exploited to chemic

72 lforhodamine b, zidovudine, and bovine serum albumin as model hydrophilic drugs, we found tapped coat

73 We further identify albumin-associated macropinocytosis and endocytosis as a

74 In summary, site-specific loading of drug to albumin at 1:1 ratio allowed the conjugate to better mai

75 fied by X-ray crystallography in human serum albumin at drug site 3, which is also known as subdomain

76 osphatase [ALP], total bilirubin [TBIL], and albumin) at three time points (preinfection baseline, ad

77 es the mechanistic basis for exploitation in albumin-based drug designs engineered to optimise this p

78 Albumin-based hydrogels are increasingly attractive in t

79 we have investigated the use of MRI-visible, albumin-based nanoclusters for noninvasive, localized an

80 ratory-related (platelet count < 50 x 109/L, albumin below normal, LDH above normal at time of admiss

81 Albumin binder optimization showed that (68)Ga-HTK03055

82 mized affinity-modifying group and optimized albumin binders to maximize the tumor-to-kidney absorbed

83 The optimized affinity-modifying group and albumin binders were combined, and the resulting derivat

84 bearing various affinity-modifying groups or albumin binders were synthesized and evaluated by PET/CT

85 this purpose, two different PBs derived from Albumin Binding Domain (ABDwt) of streptococcal protein

86 The albumin binding facilitates initial high plasma exposure

87 IgG and albumin binding to FcRn is pH-dependent, which results i

88 Human serum albumin binding was measured by affinity high-performanc

89 ogs and ~70 h in man is achieved by a strong albumin binding, and by lowering the insulin receptor af

90 tested the effect of adding a streptococcal albumin-binding domain (ABD) and a llama single-domain a

91 ach is to attach drug leads to the G-related albumin-binding domain (ABD) to bind albumin and evade c

92 s also illustrate the benefits of linking an albumin-binding domain to the single-domain ADCs.

93 A construct lacking an albumin-binding domain was rapidly cleared, leading to l

94 -Gly and N-(4-(p-methoxyphenyl)butanoyl)-Gly albumin-binding motifs generated HTK03121 and HTK03123,

95 igher in vivo MR signal enhancement from the albumin-binding probe (p = 0.047) and a smaller nonenhan

96 These results indicate that MRI with an albumin-binding probe may enable noninvasive assessment

97 of magnetic resonance imaging (MRI) with an albumin-binding probe to assess changes in vascular perm

98 ove the therapeutic index of current in situ albumin-binding prodrugs, we developed albumin-drug conj

99 g accumulation in tumors compared to in situ albumin-binding prodrugs.

100 The ratio of albumin-binding-probe enhancement of the aneurysm wall t

101 lity demonstrated an increased uptake of the albumin-binding-probe.

102 ency virus status with CD4 count, age, serum albumin, body mass index, and pre-existing hearing loss.

103 Meanwhile, the introduction of bovine serum albumin (BSA) and antibody (Ab) enhanced the dispersity

104 avior of two model proteins- i) bovine serum albumin (BSA) and ii) beta-galactosidase (beta-gal), was

105 ydrolyzed iron oxide-associated bovine serum albumin (BSA) and the factors that affected the proteoly

106 with a 4-plex labeled sample of bovine serum albumin (BSA) and yeast lysates mixed at different ratio

107 L) after passive adsorption and bovine serum albumin (BSA) as a blocking agent generated a moderate s

108 human serum albumin (HSA), and bovine serum albumin (BSA) as model target proteins.

109 inone core allowed reduction of bovine serum albumin (BSA) binding (63c, 63d).

110 re collected from a solution of bovine serum albumin (BSA) digested by trypsin as an enzymatic model

111 of a yeast proteome spiked with bovine serum albumin (BSA) over a 10-fold dynamic range.

112 portant roles in the ability of bovine serum albumin (BSA) to form stable nanostructures with bioacti

113 coside (CYG) through binding to bovine serum albumin (BSA) was investigated at pH 3.0 using atomic fo

114 ents, antibodies against native bovine serum albumin (BSA) were detected.

115 report, a stepwise unfolding of bovine serum albumin (BSA) with guanidine hydrochloride (GuHCl) has b

116 leaves at different rates with bovine serum albumin (BSA), a molecular substitute for detritus.

117 lbumin hydrogels has focused on bovine serum albumin (BSA), leaving human serum albumin (HSA) compara

118 he bilayer were backfilled with bovine serum albumin (BSA).

119 (T(d)) and heat-set gelation of bovine serum albumin (BSA).

120 ing small (glycerol) and large (bovine serum albumin; BSA) analyte molecules, indicating that the hyd

121 ectiveness to reduce wine turbidity than egg albumin but modified in different way the phenolic compo

122 ex vivo ensures complete drug binding to the albumin carrier and achieves excellent antitumor efficac

123 mimetic nanoparticles (cationic bovine serum albumin (CBSA) conjugated siS100A4 and exosome membrane

124 We investigate the hypothesis that albumin cellular recruitment is increased by higher huma

125 tion yield (total proteins, helianthinin and albumins), chlorogenic acids covalently bound to protein

126 ) retained the native secondary structure of albumin compared to conjugate with a higher DAR of 3 (AL

127 irect imaging of the transport of Evans blue-albumin complex in brains of rats subjected to recurrent

128 eport the crystal structures of equine serum albumin complexed with four NSAIDs (ibuprofen, ketoprofe

129 re noted for inflammatory (total protein and albumin concentrations) and hepatic (ALT, AST) parameter

130 debridement, inflammatory (total protein and albumin concentrations) and hepatic (AST) parameters ret

131 on, haemoglobin A1c (HbA1c) levels and urine albumin creatinine ratio.

132 uation) trial in patients with T2DM, urinary albumin-creatinine ratio >300 mg/g, and estimated glomer

133 HbA1c levels, urinary albumin-creatinine ratio (p = 0.041), average cell size

134 provided GWAS summary data for eGFR, urinary albumin-creatinine ratio (UACR), BUN, and serum urate.

135 4 or 45-59 ml/min per 1.73 m(2) with urinary albumin/creatinine (ACR) >=50 mg/g and serum bicarbonate

136 >=1 ml/min per 1.73 m(2) per year, or urine albumin/creatinine ratio >=30 mg/g.

137 diabetes duration, waist/hip ratio, urinary albumin/creatinine ratio (ACR) and fasting C-peptide.

138 Total urine output, urinary protein, albumin/creatinine ratio, flow rate, resistance were mea

139 wer baseline eGFR, and higher baseline urine albumin/creatinine ratio.

140 ase and no history of gout who had a urinary albumin:creatinine ratio of 265 or higher (with albumin

141 .7 ml per minute per 1.73 m(2); median urine albumin:creatinine ratio, 716.9; mean serum urate level,

142 The presence of albumin decreased Klotho expression in the POD-ATTAC mou

143 model and experimentally via osmotic agents albumin, dextran 70, and mannitol.

144 the enrichment step from spiked bovine serum albumin digests were >80% for the commercial Fe-IMAC kit

145 er injection (65.2% vs 35.0%, P = 0.05), and albumin dissolvent (68.1%) compared to fresh frozen plas

146 re reliably identified with ICG dose >=1 mg, albumin dissolvent, post-injection lung ventilation, rad

147 factor in fetal bovine serum, identified as albumin, does not interfere with the catalytic activity

148 The resulting albumin-drug conjugate with a drug to albumin ratio (DAR

149 situ albumin-binding prodrugs, we developed albumin-drug conjugates with a controlled loading that a

150 sted source of amino acids; a role driven by albumin engagement with its cognate cellular recycling n

151 f B(T) correlated inversely to the bilirubin-albumin equilibrium association binding constant (R(2) =

152 Transition of albumin excretion from normal to microalbuminuria, a 5-f

153 Glomerular filtration rate (GFR) and urinary albumin excretion rate (UAER) are used to diagnose and c

154 The mean urinary albumin excretion rate after washout was 40% (95% CI, 0

155 f glomerular filtration rate (GFR) and urine albumin excretion, and kidney injury was evaluated by hi

156 rols, and positively correlated with urinary albumin excretion.

157 ssion of specific hepatic markers as well by albumin expression and secretion, is severely compromise

158 elded 46.83% and 59.16% of total protein and albumin extraction yield, 1.730 and 1.998 mg.g(-1) of ch

159 Median human serum albumin for OriCols was 14.9 mug/ml, whereas Merocels an

160 SCs ex vivo for >1 month under fully defined albumin-free conditions.

161 similarities with epitopes of allergenic 2S albumins from peanut (Ara h 2 and 6) and Brazil nut (Ber

162 immunity measures (serum IgG, serum protein, albumin, globulin and total protein concentrations, tota

163 ease, corresponds to a 3.5-fold elevation in albumin glomerular filtration, supporting the use of mic

164 reference molecules (dopamine, bovine serum albumin, glucose and elongated peptide) was negligible.

165 lla asiatica phenolics (CAP) on bovine serum albumin glycoxidation in a BSA-glucose model in vitro.

166 re frequent in the no-albumin group than the albumin group (70% versus 30%; P = 0.001), with higher i

167 PICD was more frequent in the no-albumin group than the albumin group (70% versus 30%; P

168 ents with score 0 (baseline LSM <= 17.3 kPa, albumin >4.2 g/dL, and 1-year DeltaLSM > 25.5%) versus 5

169 highly abundant proteins such as human serum albumin (>10(10) more abundant than cTnI).

170 RA in rescuing RA/RAR activity repressed by albumin, high glucose, angiotensin II, aldosterone, cisp

171 d was associated with older age, lower serum albumin, higher blood neutrophil counts, and greater pre

172 The binding of JMS-053 to human serum albumin, however, did not markedly alter the overall alb

173 54, P = 0.02), diabetes (HR 2.39, P = 0.01), albumin (HR 0.35, P = 0.001), and GRS score >0.597 (HR 2

174 8; 95% CI = 1.2-2.6; P < 0.01) and low serum albumin (HR = 2.1; 95% CI = 1.5-2.9; P < 0.01) were sign

175 s the target biomarker proteins (human serum albumin (HSA) and human immunoglobulin G (HIgG)) and ach

176 and kinetics of binding between human serum albumin (HSA) and resveratrol (RES) or its analog (RESAn

177 to investigate the potential of human serum albumin (HSA) as a solubilising agent/drug delivery vehi

178 The knowledge on human serum albumin (HSA) binding is of utmost importance as it affe

179 ine serum albumin (BSA), leaving human serum albumin (HSA) comparatively understudied.

180 icle (SPNP) based on polymerized human serum albumin (HSA) equipped with the cell-penetrating peptide

181 thione S-transferase pi (hGSTP), human serum albumin (HSA), and bovine serum albumin (BSA) as model t

182 expressed extracellular protein, human serum albumin (HSA), inhibits alphaS oligomer (alphaS(n)) toxi

183 scorbic acid were incubated with human serum albumin (HSA).

184 details for the interaction with human serum albumin (HSA).

185 ated good biocompatibility of functionalised albumin hydrogels compared to untreated samples.

186 The majority of research on albumin hydrogels has focused on bovine serum albumin (B

187 iked with microproteinuria concentrations of albumin, immunoglobulin, and hemoglobin, giving a predic

188 educed ESA requirements, and increased serum albumin in patients on hemodialysis with inflammation an

189 ctive binding to the transport protein serum albumin in PBS buffer at ambient conditions.

190 solutions in a complex matrix (bovine serum albumin in phosphate buffered saline) is also demonstrat

191 imit of ~110 fg/mL biotinylated bovine serum albumin in serum.

192 on of the biophysics of binding of an ABD to albumin in solution could shed light on this question.

193 radation and extend the half-life of IgG and albumin in the circulation.

194 SS1P, proximal tubular cells are damaged and albumin in the urine is increased.

195 umulation in tumours could reflect a role of albumin in transport of endogenous nutrient cargos requi

196 c acids covalently bound to helianthinin and albumins in aqueous extract, respectively.

197 of the physicochemical properties of the 2S albumins in peanuts, tree nuts, and sesame seeds will en

198 Albumin induced features of ER stress in renal tubular c

199 Albumin infusion decreases the incidence of PICD and mor

200 aracentesis in cirrhosis and is reduced with albumin infusion.

201 st-volume paracentesis (MVP) and the role of albumin infusion.

202 ons in the CP without inducing extravascular albumin leakage or major leukocyte infiltration into the

203 ic-reperfused cortex and negligible vascular albumin leakage.

204 ty (area under the curve >0.70), as were low albumin level, lymphocyte count, monocyte count, and rat

205 zes the difficulties in interpreting urinary albumin levels in early disease models.

206 Serum albumin levels in the cortex, a measure of BBB breakdown

207 significantly with urinary nephrin, IgG and albumin levels, suggesting suPAR as a pathophysiological

208 prevent SS1P-mediated kidney damage, reduce albumin loss in urine, and alleviate capillary leak synd

209 lnutrition was measured using serum markers (albumin <3.5 g/dL) as well as body mass index (BMI) as a

210 chnetium 99m ((99m)Tc) macroaggregated human albumin (MAA) SPECT/CT.

211 318; P < .001), hemoglobin, hematocrit, and albumin may predict colectomy.

212 The reversible binding of JMS-053 to serum albumin may serve to increase JMS-053's plasma half-life

213 w the structural similarities among their 2S albumins may account for observed clinical cross-reactiv

214 umin:creatinine ratio of 265 or higher (with albumin measured in milligrams and creatinine in grams)

215 a urinary albumin-to-creatinine ratio (with albumin measured in milligrams and creatinine measured i

216 nephrotic range proteinuria (NNRP) and serum albumin measurements in relation to PLA2R-AB status.

217 f the particle supernatant with bovine serum albumin mitigates the negative effects of free or bound

218 er, ion mobility resolution for bovine serum albumin (MW ~ 68 kDa) is less than ~20, which arises fro

219 umin (8 g/dL of ascitic fluid; n = 40) or no albumin (n = 40) and serially followed to detect PICD.

220 The T12 peptide-modified albumin nanoparticles coloaded with regorafenib and disu

221 ER stress with 4-PBA decreased the effect of albumin on Klotho protein levels without altering mRNA l

222 ore sensitive markers of PT dysfunction than albumin or alpha(1) -m, and suggest that reduced PT sodi

223 s glutathione S-transferase pi (GSTP), serum albumin, or Keap1.

224 inogen activator, endovascular treatment, IV albumin, or placebo.

225 d to DMSO/phosphate buffered saline (PBS) or albumin/PBS solutions in an in vitro M. tuberculosis-inf

226 In macroalbuminuria, small albumin permeability changes produce large changes in ex

227 ts, faecal calprotectin, C-reactive protein, albumin, platelet count, 25(OH) vitamin D, or 1,25(di-OH

228 Predictors included age, preoperative albumin, platelet count, bilirubin, surgery category, em

229 of three Charged Model Molecules (CMMs, egg albumin, polyphenols and riboflavin) was carried out to

230 A bovine serum albumin pretreatment protocol was developed to stabilize

231 By conjugating the drug to albumin prior to administration minimized premature clea

232 nctional analyses performance (i.e. urea and albumin production, cytochrome P450 activity and inducti

233 m whole blood, volume metering, depletion of albumin, protein digestion with trypsin, and stabilizati

234 ariable results was based on detection of 2S albumin proteins.

235 n and aloe-emodin derivatives to human serum albumin ranged from -7.30 and -10.62 kcal/mol.

236 ulting albumin-drug conjugate with a drug to albumin ratio (DAR) of 1 (ALDC1) retained the native sec

237 n in CSF, and in BBB permeability (CSF/serum albumin ratio).

238 n, all P < .05), and an increased CSF:plasma albumin ratio, a marker of blood-brain barrier breakdown

239 for the C-terminal half of cubilin in renal albumin reabsorption.

240 ith mechanistic data suggesting hFcRn-driven albumin recruitment for increased cellular growth that h

241 tal Fc receptor (FcRn) that mediates IgG and albumin recycling also participates in cellular response

242 nd Ca(2+) cations, revealing suitable for RT albumin removal within 120 min.

243 (sucrose, dopamine, starch, and bovine serum albumin), resulting in negligible cross-reactivity excep

244 spleen of a systemically administered serum albumin (SA)-IL-4 fusion protein leads to higher efficac

245 loodstream, NSAIDs are mostly bound to serum albumin (SA).

246 asmonic construct consists of a bovine serum albumin scaffold with approximately 210 IRDye 800CW fluo

247 y 1:400 horse radish peroxidase/bovine serum albumin, sensitivity to 100 attomoles, recovery 89.51%,

248 EsTo) consists of nine variables: bilirubin, albumin, serum alkaline phosphatase (SAP) times the uppe

249 ctures in the organoid displayed dextran and albumin size selectivity across their glomerular filtrat

250 sing IDA in intact and digested bovine serum albumin solutions using the TCN (98 and 100%, respective

251 The regulation was albumin specific since it was neither observed in the an

252 uted at technetium 99m macroaggregated human albumin SPECT/CT was associated with better overall surv

253 however, did not markedly alter the overall albumin structure.

254 of HSCs in media that contain poorly defined albumin supplements such as bovine serum albumin.

255 h (DeltaB(pp) = 24 mG), a lower affinity for albumin than Finland trityl, and a high aqueous solubili

256 In the presence of serum albumin, the potency of JMS-053 as an in vitro inhibitor

257 was removed and replaced with 5% human serum albumin to reduce haemoglobin concentration (n = 8).

258 ltration rate [eGFR] <60 ml/min/1.73 m(2) or albumin-to-creatine ratio >300 mg/g).

259 Urine albumin-to-creatinine ratio (ACR) and protein-to-creatin

260 Urinary albumin-to-creatinine ratio (ACR) is a marker of diabeti

261 lomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR), with cancer incidence

262 We also identified 2 known loci for urine albumin-to-creatinine ratio (BCL2L11 rs116907128, P=5.6x

263 dded kidney measures was cysC-eGFR and urine albumin-to-creatinine ratio (DeltaC=0.019 [95% CI, 0.015

264 underpinnings with the exception of urinary albumin-to-creatinine ratio (Rg = 0.64; SE = 0.22; P = 0

265 llele frequency=0.01, P=1.6x10(-8)) or urine albumin-to-creatinine ratio (rs527493184 at ZBTB16, mino

266 lementary prognostic value of baseline urine albumin-to-creatinine ratio (uACR) and plasma soluble tu

267 learance; albuminuria was estimated by urine albumin-to-creatinine ratio (UACR); and M/I was estimate

268 Eligible patients had a urinary albumin-to-creatinine ratio (with albumin measured in mi

269 uded patients with type 2 diabetes and urine albumin-to-creatinine ratio 30 to 5000 mg/g and an estim

270 been assessed in 2006 to 2010 with the urine albumin-to-creatinine ratio and estimated glomerular fil

271 timated glomerular filtration rate and urine albumin-to-creatinine ratio in up to 12 207 Hispanics/La

272 diabetic retinopathy, or they had a urinary albumin-to-creatinine ratio of 300 to 5000 and an eGFR o

273 =9.3x10(-11)) and validated 8 loci for urine albumin-to-creatinine ratio previously identified in the

274 te was 42.3 ml/min/1.73 m2, and median urine albumin-to-creatinine ratio was 3.4 mg/mmol.

275 c levels, creatinine levels, and the urinary albumin-to-creatinine ratio were recorded.

276 y measures (creat-eGFR, cysC-eGFR, and urine albumin-to-creatinine ratio) led to significant improvem

277 n, sST2, galectin-3, cystatin-C, and urinary albumin-to-creatinine ratio.

278 and longitudinal changes in eGFR and urinary albumin-to-creatinine ratio.

279 base model to which we added eGFR and urine albumin-to-creatinine ratio.

280 e association of lymphocyte count with urine albumin-to-creatinine ratio.

281 ionally, nephrotic-range albuminuria with an albumin-to-creatinine-ratio (ACR) >220 mg/mmol was a sig

282 ween log(ACR) and log(PCR), with the implied albumin-to-protein ratio increasing from <30% in normal

283 and PCR, with men generally having a higher albumin-to-protein ratio.

284 polarized HLCs secrete cargo directionally: Albumin, urea, and lipoproteins are secreted basolateral

285 examine the binding of an ABD to human serum albumin using isothermal titration calorimetry and asses

286 tial to be exploited with high hFcRn-binding albumin variants for targeted therapies.

287 E (MMAE) was conjugated ex vivo to Cys34 of albumin via a cathepsin B-sensitive dipeptide linker to

288 A-21 in human serum albumin and bovine serum albumin was almost identical to that in PBS.

289 ted for growth in medium where extracellular albumin was the obligate source of the essential amino a

290 A mass balance model based on bovine serum albumin-water (D(BSA/w)) and liposome-water distribution

291 e WL, while CysC >= 1.5 mg/L, sarcopenia and albumin were independent predictors of mortality.

292 spectra of Escherichia coli and bovine serum albumin were recorded.

293 Globulin and albumin were the predominant soluble protein fractions.

294 elet-derived growth factor AB [PDGF-AB], and albumin) were measured in fresh and lyophilized serum.

295 ladib has been found mainly bound on HDL and albumin when it is incubated with human serum.

296 A3 binds to at least one site on human serum albumin, which is likely to extend the compound's plasma

297 acute kidney injury (AKI) were randomized to albumin with infusion of terlipressin (2-12 mg/day; n =

298 inogen has a higher affinity for SWCNTs than albumin, with a fibrinogen on-rate constant 1.61-fold gr

299 arness the intrinsic transport properties of albumin yet improve the therapeutic index of current in

300 al covariates such as performance status and albumin, yielding AUCs as high as 0.84-0.85 for the pred